PMID- 36018815 OWN - NLM STAT- MEDLINE DCOM- 20230116 LR - 20230308 IS - 1460-2083 (Electronic) IS - 0964-6906 (Print) IS - 0964-6906 (Linking) VI - 32 IP - 1 DP - 2023 Jan 1 TI - Large registry-based analysis of genetic predisposition to tuberculosis identifies genetic risk factors at HLA. PG - 161-171 LID - 10.1093/hmg/ddac212 [doi] AB - Tuberculosis is a significant public health concern resulting in the death of over 1 million individuals each year worldwide. While treatment options and vaccines exist, a substantial number of infections still remain untreated or are caused by treatment resistant strains. Therefore, it is important to identify mechanisms that contribute to risk and prognosis of tuberculosis as this may provide tools to understand disease mechanisms and provide novel treatment options for those with severe infection. Our goal was to identify genetic risk factors that contribute to the risk of tuberculosis and to understand biological mechanisms and causality behind the risk of tuberculosis. A total of 1895 individuals in the FinnGen study had International Classification of Diseases-based tuberculosis diagnosis. Genome-wide association study analysis identified genetic variants with statistically significant association with tuberculosis at the human leukocyte antigen (HLA) region (P < 5e-8). Fine mapping of the HLA association provided evidence for one protective haplotype tagged by HLA DQB1*05:01 (P = 1.82E-06, OR = 0.81 [CI 95% 0.74-0.88]), and predisposing alleles tagged by HLA DRB1*13:02 (P = 0.00011, OR = 1.35 [CI 95% 1.16-1.57]). Furthermore, genetic correlation analysis showed association with earlier reported risk factors including smoking (P < 0.05). Mendelian randomization supported smoking as a risk factor for tuberculosis (inverse-variance weighted P < 0.05, OR = 1.83 [CI 95% 1.15-2.93]) with no significant evidence of pleiotropy. Our findings indicate that specific HLA alleles associate with the risk of tuberculosis. In addition, lifestyle risk factors such as smoking contribute to the risk of developing tuberculosis. CI - (c) The Author(s) 2022. Published by Oxford University Press. FAU - Tervi, Anniina AU - Tervi A AUID- ORCID: 0000-0002-9857-2132 AD - Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland. FAU - Junna, Nella AU - Junna N AUID- ORCID: 0000-0002-5953-5523 AD - Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland. FAU - Broberg, Martin AU - Broberg M AUID- ORCID: 0000-0002-5419-9479 AD - Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland. FAU - Jones, Samuel E AU - Jones SE AUID- ORCID: 0000-0003-0153-922X AD - Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland. CN - FinnGen FAU - Strausz, Satu AU - Strausz S AUID- ORCID: 0000-0001-6778-4848 AD - Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland. FAU - Kreivi, Hanna-Riikka AU - Kreivi HR AUID- ORCID: 0000-0002-9361-8322 AD - Department of Pulmonology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. FAU - Heckman, Caroline A AU - Heckman CA AUID- ORCID: 0000-0002-4324-8706 AD - Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland. FAU - Ollila, Hanna M AU - Ollila HM AUID- ORCID: 0000-0002-5302-6429 AD - Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland. AD - Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. AD - Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA. LA - eng GR - MC_PC_17228/MRC_/Medical Research Council/United Kingdom GR - MC_QA137853/MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Hum Mol Genet JT - Human molecular genetics JID - 9208958 RN - 0 (HLA-DQ beta-Chains) RN - 0 (HLA-DRB1 Chains) SB - IM MH - Humans MH - *Genetic Predisposition to Disease MH - Genome-Wide Association Study MH - *Tuberculosis/genetics MH - HLA-DQ beta-Chains/genetics MH - HLA-DRB1 Chains/genetics MH - Haplotypes/genetics MH - Risk Factors MH - Alleles MH - Gene Frequency PMC - PMC9838093 FIR - Partinen, Markku IR - Partinen M FIR - Pirinen, Matti IR - Pirinen M FIR - Bryson, Bryan IR - Bryson B EDAT- 2022/08/27 06:00 MHDA- 2023/01/17 06:00 PMCR- 2022/08/26 CRDT- 2022/08/26 13:22 PHST- 2022/02/25 00:00 [received] PHST- 2022/07/27 00:00 [revised] PHST- 2022/08/23 00:00 [accepted] PHST- 2022/08/27 06:00 [pubmed] PHST- 2023/01/17 06:00 [medline] PHST- 2022/08/26 13:22 [entrez] PHST- 2022/08/26 00:00 [pmc-release] AID - 6677343 [pii] AID - ddac212 [pii] AID - 10.1093/hmg/ddac212 [doi] PST - ppublish SO - Hum Mol Genet. 2023 Jan 1;32(1):161-171. doi: 10.1093/hmg/ddac212.